FIXIWEL-CV is a paediatric combination designed to provide broader antibacterial coverage in appropriate susceptible infections through the complementary action of a cephalosporin and beta-lactamase inhibitor. Its suspension format enables convenient administration in children. A differentiated PCD Pharma Paediatric Antibiotic product.
To inhibit certain beta-lactamase enzymes.
No.
Use only when prescribed and complete the course. Check allergy history carefully and consult the physician for severe diarrhea or allergic symptoms.
Diarrhea, nausea, vomiting, abdominal discomfort, headache and skin rash may occur.
FIXIWEL-CV: Cefixime inhibits bacterial cell-wall synthesis, while Clavulanic Acid inhibits certain beta-lactamases, helping protect the antibiotic from enzymatic degradation.
